Generic placeholder image

Cardiovascular & Hematological Agents in Medicinal Chemistry

Author(s): Omid Mehrpour, Effat Alemzadeh, Saeedeh Ghasemi, Tahereh Farkhondeh and Masood Ziaee*

DOI: 10.2174/1871525721666230518101627

DownloadDownload PDF Flyer Cite As
Differences in Clinical and Lab Characteristics of Sepsis between Opium User Patients and Patients with No Illicit Drug Addiction

Page: [151 - 158] Pages: 8

  • * (Excluding Mailing and Handling)

Abstract

Background: Sepsis is a significant cause of mortality worldwide. This study aimed to compare clinical and laboratory characteristics of sepsis in patients addicted to illicit drugs versus patients with no illicit drug addiction.

Methods: In this cross-sectional study, all patients hospitalized with sepsis diagnosis were recruited within six months from September to March 2019. Sixty patients for each group (illicit drugaddicted and non-addicted individuals) were selected. The data relating to illicit drug consumption, serum indices, the current focus of infection, duration of hospitalization, and disease outcomes were collected. Patients who had an illicit drug addiction were compared with non-addicted patients in terms of clinical and laboratory parameters. The data collected were analyzed using SPSS software (version 19).

Results: The bacterial load in the urine culture was statistically significant in both groups and higher in the non-addicted group. The frequency distributions of focus of infection, duration of hospitalization, and outcome were not significantly different between the two groups. The serum sodium and total neutrophils were significantly higher in the addicted group. However, the MCHC level was significantly lower (p < 0.05).

Conclusion: Opium may have stimulated the immune system and reduced bacterial infection in septic patient users.

Graphical Abstract

[1]
Afkar, A.; Rezvani, S.M.; Sigaroudi, A.E. Measurement of factors influencing the relapse of addiction: A factor analysis. Int. J. High Risk Behav. Addict., 2017, 6(3), e32141.
[2]
Wang, J.; Barke, R.A.; Ma, J.; Charboneau, R.; Roy, S. Opiate abuse, innate immunity, and bacterial infectious diseases. Arch. Immunol. Ther. Exp., 2008, 56(5), 299-309.
[http://dx.doi.org/10.1007/s00005-008-0035-0] [PMID: 18836861]
[3]
Börner, C.; Warnick, B.; Smida, M.; Hartig, R.; Lindquist, J.A.; Schraven, B.; Höllt, V.; Kraus, J. Mechanisms of opioid-mediated inhibition of human T cell receptor signaling. J. Immunol., 2009, 183(2), 882-889.
[http://dx.doi.org/10.4049/jimmunol.0802763] [PMID: 19561113]
[4]
Hilburger, M.E.; Adler, M.W.; Truant, A.L.; Meissler, J.J., Jr; Satishchandran, V.; Rogers, T.J.; Eisenstein, T.K. Morphine induces sepsis in mice. J. Infect. Dis., 1997, 176(1), 183-188.
[http://dx.doi.org/10.1086/514021] [PMID: 9207365]
[5]
Meng, J.; Banerjee, S.; Li, D.; Sindberg, G.M.; Wang, F.; Ma, J.; Roy, S. Opioid exacerbation of gram-positive sepsis, induced by gut microbial modulation, is rescued by IL-17A neutralization. Sci. Rep., 2015, 5(1), 10918.
[http://dx.doi.org/10.1038/srep10918] [PMID: 26039416]
[6]
Greeneltch, K.M.; Haudenschild, C.C.; Keegan, A.D.; Shi, Y. The opioid antagonist naltrexone blocks acute endotoxic shock by inhibiting tumor necrosis factor-α production. Brain Behav. Immun., 2004, 18(5), 476-484.
[http://dx.doi.org/10.1016/j.bbi.2003.12.001] [PMID: 15265541]
[7]
Boland, J.W.; Foulds, G.A.; Ahmedzai, S.H.; Pockley, A.G. A preliminary evaluation of the effects of opioids on innate and adaptive human in vitro immune function. BMJ Support. Palliat. Care, 2014, 4(4), 357-367.
[http://dx.doi.org/10.1136/bmjspcare-2013-000573] [PMID: 24644198]
[8]
Karam, G.A.; Reisi, M.; Kaseb, A.A.; Khaksari, M.; Mohammadi, A.; Mahmoodi, M. Effects of opium addiction on some serum factors in addicts with non-insulin-dependent diabetes mellitus. Addict. Biol., 2004, 9(1), 53-58.
[http://dx.doi.org/10.1080/13556210410001674095] [PMID: 15203439]
[9]
Shakeri, R.; Malekzadeh, R.; Etemadi, A.; Nasrollahzadeh, D.; Aghcheli, K.; Sotoudeh, M.; Islami, F.; Pourshams, A.; Pawlita, M.; Boffetta, P.; Dawsey, S.M.; Abnet, C.C.; Kamangar, F. Opium: An emerging risk factor for gastric adenocarcinoma. Int. J. Cancer, 2013, 133(2), 455-461.
[http://dx.doi.org/10.1002/ijc.28018] [PMID: 23319416]
[10]
Ghazavi, A.; Solhi, H.; Moazzeni, S.M.; Rafiei, M.; Mosayebi, G. Cytokine profiles in long-term smokers of opium (Taryak). J. Addict. Med., 2013, 7(3), 200-203.
[http://dx.doi.org/10.1097/ADM.0b013e31828baede] [PMID: 23519052]
[11]
Kaushik, K.S.; Kapila, K.; Praharaj, A.K. Shooting up: The interface of microbial infections and drug abuse. J. Med. Microbiol., 2011, 60(4), 408-422.
[http://dx.doi.org/10.1099/jmm.0.027540-0] [PMID: 21389334]
[12]
Dublin, S.; Walker, R.L.; Jackson, M.L.; Nelson, J.C.; Weiss, N.S.; Korff, M.; Jackson, L.A. Use of opioids or benzodiazepines and risk of pneumonia in older adults: A population-based case-control study. J. Am. Geriatr. Soc., 2011, 59(10), 1899-1907.
[http://dx.doi.org/10.1111/j.1532-5415.2011.03586.x] [PMID: 22091503]
[13]
Mirzaeipour, F.; Azdaki, N.; Mohammadi, G. The effects of opium addiction through different administration routes on inflammatory and coagulation factors. J. Kerman Univ. Med. Sci., 2013, 20(3), 30.
[14]
Salimi, V.; Hennus, M.P.; Mokhtari-Azad, T.; Shokri, F.; Janssen, R.; Hodemaekers, H.M.; Rygiel, T.P.; Coenjaerts, F.E.J.; Meyaard, L.; Bont, L. Opioid receptors control viral replication in the airways. Crit. Care Med., 2013, 41(1), 205-214.
[http://dx.doi.org/10.1097/CCM.0b013e31826767a8] [PMID: 23222260]
[15]
Mami, S.; Nemati, M.; Salati, A.P.; Monfared, A.L.; Jahromi, M.N. Evaluating antibacterial characteristics of opium. Glob. Vet., 2012, 9, 89-91.
[16]
Choi, H.; Song, I.A.; Oh, T.K. Association of opioid use in the week before death among patients with advanced lung cancer having sepsis. Cancer Contr., 2019, 26(1), 1-7.
[http://dx.doi.org/10.1177/1073274819871326]
[17]
Glattard, E.; Welters, I.D.; Lavaux, T.; Muller, A.H.; Laux, A.; Zhang, D.; Schmidt, A.R.; Delalande, F.; Laventie, B.J.; Dirrig-Grosch, S.; Colin, D.A.; Van Dorsselaer, A.; Aunis, D.; Metz-Boutigue, M.H.; Schneider, F.; Goumon, Y. Endogenous morphine levels are increased in sepsis: A partial implication of neutrophils. PLoS One, 2010, 5(1), e8791.
[http://dx.doi.org/10.1371/journal.pone.0008791] [PMID: 20098709]